wire - news in brief
Category
Results 301 - 349 of 349.
EPFL's smart living lab, located on the Fribourg campus, is at a pivotal moment in its development. Martin Gonzenbach, the lab's new director of operations, tells us why.
Novartis receives FDA approval for Egaten for the treatment of fascioliasis, a neglected tropical disease
Egaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the only treatment recommended by the WHO Fascioliasis, commonly known as liver fluke infes
Egaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the only treatment recommended by the WHO Fascioliasis, commonly known as liver fluke infes
7 challenges facing research and investment in primary brain tumours
Johanna Joyce, Ludwig member, co-signs a position paper on the challenges the scientific community faces in the fight against primary brain tumours On the initiative of Cancer Research UK, an international panel of brain cancer researchers and clinicians assessed the most important challenges ahead in the development of effective treatmens for patients.
Johanna Joyce, Ludwig member, co-signs a position paper on the challenges the scientific community faces in the fight against primary brain tumours On the initiative of Cancer Research UK, an international panel of brain cancer researchers and clinicians assessed the most important challenges ahead in the development of effective treatmens for patients.
Interdisciplinary, interconnected and oriented towards a sustainable future: These words describe Kristina Orehounig just as aptly as they describe the Empa laboratory "Urban Energy Systems", which she is heading since February 2018. She has chosen an unusual path to her current scientific discipline - but that is precisely what she sees as an advantage in her day-to-day research.
This summer, 40 international scientists will participate in the GLACE expedition around Greenland in order to study the effects of climate change in that region.
People are evidently no good at predicting their own happiness or unhappiness: key life events such as marriage, invalidity or the death of a partner affect well-being for less time than those affected think.
The first rapid screening test for cancer developed by EPFL spin-off Lunaphore is being released today.
At the beginning of the 1930s, when European countries were sealing themselves off, Switzerland opened the internationally oriented Jungfraujoch research station.
Roche submits supplemental biologics license application to the US FDA for Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche's application is being reviewed under the US FDA's Real-Time Oncology Review and Assessment Aid pilot programmes Kadcyla was granted Breakthrough Therapy Designation for this application Ro
Roche's application is being reviewed under the US FDA's Real-Time Oncology Review and Assessment Aid pilot programmes Kadcyla was granted Breakthrough Therapy Designation for this application Ro
The first call for proposal for the EPFL Open Science Fund attracted nearly 50 propositions. Nine projects were selected and will receive support to develop ideas fostering open and reproducible research on campus, and beyond. In September 2018, EPFL President Martin Vetterli announced the creation of the Open Science Fund to support the best ideas from everyone on campus with a total of CHF 3 Mio over the period 2019-2021.
CHMP recommends EU approval of Roche’s Tecentriq in combination with Avastin and chemotherapy as an initial treatment for lung cancer
Recommendation based on the Phase III IMpower150 study which showed that Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) and chemotherapy (paclitaxel and carboplatin) helped people
Recommendation based on the Phase III IMpower150 study which showed that Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) and chemotherapy (paclitaxel and carboplatin) helped people
CHMP recommends EU approval of Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis in a prospective intra-patient comparison First new class of medicine in nearly 20 years for people wit
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis in a prospective intra-patient comparison First new class of medicine in nearly 20 years for people wit
Solar energy for a circular economy
A sustainable alternative to the fossil-based, energy-intensive production of fuels and basic products of the chemical industry, based solely on solar energy and universally available resources: This
A sustainable alternative to the fossil-based, energy-intensive production of fuels and basic products of the chemical industry, based solely on solar energy and universally available resources: This
Although it is widely accepted that governance rules play a major role in the smooth running of businesses and contribute to market equilibrium, how can we measure businesses' degree of responsibility in this area?
Gardens in urban areas can harbor a remarkable diversity of species. This has been found by researchers from the University of Basel in a field study carried out with the support of private garden owners from the Basel region. Furthermore, the research team shows that nature-friendly garden management and design can largely compensate for the negative effects of urbanization on biodiversity.
A beekeeper teamed up with the Signal Processing Laboratory 5 and a group of EPFL students to develop an app that counts the number of Varroa mites in beehives.
Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) - other company programmes in AD continue
At three years, 88.3% of people treated with Kadcyla in the adjuvant HER2-positive early breast cancer setting did not have their breast cancer return compared to 77.0% treated with Her
At three years, 88.3% of people treated with Kadcyla in the adjuvant HER2-positive early breast cancer setting did not have their breast cancer return compared to 77.0% treated with Her
Implants from the 3D printer
3D printing is finding its way into industrial manufacturing. This technology and the increasing digitalization of design and manufacturing processes - keyword "Industry 4.0" - will also play a central role in medical technology in the future. A new technology transfer centre in the canton of Solothurn will help to transfer know-how from science to industry - and at the same time accelerate research.
3D printing is finding its way into industrial manufacturing. This technology and the increasing digitalization of design and manufacturing processes - keyword "Industry 4.0" - will also play a central role in medical technology in the future. A new technology transfer centre in the canton of Solothurn will help to transfer know-how from science to industry - and at the same time accelerate research.
How do mRNAs deal with stress?
Two hallmarks of the integrated stress response of cells are the inhibition of translation and the formation of stress granules (SGs) and processing bodies (PBs). However, it is not well understood how both processes are coupled. In a study published in Molecular Cell, researchers from the Chao group applied single-molecule RNA imaging to study the interactions of mRNAs with SGs and PBs, and found out that the generally accepted assumptions about the function of granules need to be revised.
Two hallmarks of the integrated stress response of cells are the inhibition of translation and the formation of stress granules (SGs) and processing bodies (PBs). However, it is not well understood how both processes are coupled. In a study published in Molecular Cell, researchers from the Chao group applied single-molecule RNA imaging to study the interactions of mRNAs with SGs and PBs, and found out that the generally accepted assumptions about the function of granules need to be revised.
A walk-through exhibition introduces people to innovative projects from various institutes.
An EPFL researcher has developed a system based on fuel cells to reduce the carbon footprint and energy consumption of cruise ships, which are increasingly popular among vacation goers around the world.